Next Article in Journal
A Short Review on the Intranasal Delivery of Diazepam for Treating Acute Repetitive Seizures
Next Article in Special Issue
Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research
Previous Article in Journal
Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death
Previous Article in Special Issue
Extracellular Vesicles as Drug Delivery Systems in Cancer
Peer-Review Record

Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer

Pharmaceutics 2020, 12(12), 1166;
by Guillaume Sicard 1, Clément Paris 2, Sarah Giacometti 1, Anne Rodallec 1, Joseph Ciccolini 1, Palma Rocchi 2,* and Raphaëlle Fanciullino 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Pharmaceutics 2020, 12(12), 1166;
Submission received: 13 November 2020 / Revised: 26 November 2020 / Accepted: 27 November 2020 / Published: 29 November 2020
(This article belongs to the Special Issue Novel Anticancer Strategies)

Round 1

Reviewer 1 Report

Manuscript ID: pharmaceutics-1018568

The manuscript of Guillaume Sicard, Clément Paris, Sarah Giacometti, Anne Rodallec, Joseph Ciccolini, Palma Rocchi, and Raphaëlle Fanciullino as Co-authors: “Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A proof-of-concept study in prostate cancer” presents the studies regarding delivery of antisense oligonucleotide using cationic liposomes. This manuscript was resubmitted a new version, main suggestions of reviewer are included in the manuscript.

However, there are some additional issues needed to be addressed before publication:

  1. Please, use the numbers of Figures in ascending order. Authors used two times Figure 6 and divided information in the two parts.
  2. Line 235, Fig. 4, please check the quality of text into marked line.
  3. Line 285: check style points for the legend of Fig. 10.
  4. Table 1. Please use the same style point and use the same significant digits for all data.
  5. Please add in Table 2 also data regarding formulation-1.
  6. Please use the same style point for the description of Trastuzumab, sometimes authors use Trastuzumab, sometimes - trastuzumab,
  7. Please rewrite conclusions giving more detailed information and conclusion regarding your studies. Now only general information is given in conclusions.

Consequently, I do recommend accepting this manuscript for publication with minor revision.

Author Response


All requested modifications have been made in order to respond to your requests.

Best regards,

Raphaëlle Fanciullino

Author Response File: Author Response.docx

Reviewer 2 Report

The authors have fulfilled most of the suggestions pointed out in the earlier version. the manuscript may be accepted for publication.

Author Response


Would like to thank you for your review.

Best regards

Raphaëlle Fanciullino

Back to TopTop